Related Experiment Video
Updated: Apr 20, 2026
11:51
Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making
Published on: March 2, 2011
15.8K
An Overview of Testosterone Therapy.
1Southeastern Louisiana University, Carriere, MS, USA lee4185@bellsouth.net.
American Journal of Men'S Health
|November 16, 2014
Summary
Testosterone decline affects millions of men due to aging and medical conditions. Testosterone supplementation therapy (TST) is increasingly used, requiring healthcare providers to understand its causes, diagnosis, and risks.
Area of Science:
- Endocrinology
- Men's Health
- Aging Research
Background:
- Testosterone decline is common in men due to aging, illness, or medical treatments.
- Symptoms of low testosterone can be subtle and misdiagnosed.
- There's a significant rise in testosterone level testing and testosterone supplementation therapy (TST) use over the last 20 years.
Purpose of the Study:
- To provide a comprehensive overview of testosterone deficiency.
- To outline current testosterone supplementation therapy (TST) treatment options and guidelines.
- To detail the risks and benefits associated with TST.
Main Methods:
- Literature review of testosterone deficiency and TST.
- Analysis of diagnostic criteria for testosterone decline.
- Evaluation of various TST formulations and their clinical implications.
Main Results:
- Identified common causes and symptoms of testosterone decline.
- Summarized diagnostic approaches for testosterone deficiency.
- Reviewed the benefits and risks of TST, including available formulations.
Conclusions:
- Healthcare professionals must be knowledgeable about testosterone decline, its diagnosis, and TST.
- Understanding the nuances of TST is crucial for effective patient management.
- This article serves as a guide to testosterone deficiency and its treatment options.
Related Concept Videos
01:26Testosterone: Functions and Regulation
3.6K
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
3.6K
01:26Drug Administration and Therapy Phases: Overview
2.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
2.1K
01:28Drug Therapy
424
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
424
01:29Therapeutic Drug Monitoring: Affecting Factors
403
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
403
01:16Therapeutic Drug Monitoring: Overview and Classification
586
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
586
01:30Electroconvulsive Therapy
2.4K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.4K